Pro Data Export
Corcept Therapeutics Key Statistics
Current Valuation
Dividends and Shares
| Shares Outstanding | 99.81M |
| Dividend | |
| Dividend Yield | 0.00% |
| Cash Div. Payout Ratio TTM Pro | Go Pro |
| Payout Ratio TTM Pro | Go Pro |
| Latest Dividend Date | |
| Latest Ex-Dividend Date | |
| Last Split Factor | |
| Last Split Date |
Profitability
| Gross Profit Margin Quarterly | 98.62% |
| Profit Margin Quarterly | -807.8% |
| EBITDA Margin TTM Pro | Go Pro |
| Operating Margin TTM Pro | Go Pro |
Management Effectiveness
Liquidity and Solvency
| Altman Z-Score Pro | Go Pro |
| Current Ratio | 11.37 |
| Debt to Equity Ratio | 0.5128 |
| Free Cash Flow | -8.80M |
| KZ Index Pro | Go Pro |
| Tangible Common Equity Ratio Pro | Go Pro |
| Times Interest Earned TTM Pro | Go Pro |
Stock Price Performance
| Beta Pro | Go Pro |
| 1 Month Stock Returns | -2.09% |
| Year to Date Stock Returns | 30.77% |
| 1 Year Stock Returns | -51.80% |
| 3 Year Stock Returns | -42.46% |
| 52 Week High | 4.55 |
| 52 Week Low | 1.27 |
Income Statement
Cash Flow Statement
| Cash from Financing TTM | 89.57M |
| Cash from Investing TTM | -0.151M |
| Cash from Operations TTM | -36.02M |
| Capital Expenditures Quarterly Pro | Go Pro |
Balance Sheet
| Cash and ST Investments | 93.03M |
| Long Term Debt | 31.68M |
| Total Assets | 99.17M |
| Liabilities | 37.39M |
| Shareholders Equity | 61.78M |
| Book Value | 61.78M |
| Book Value Per Share | 0.6189 |
| Tangible Book Value Pro | Go Pro |
| Tangible Book Value Per Share Pro | Go Pro |
Earnings Quality
| Accruals Pro | Go Pro |
| Beneish M-Score Pro | Go Pro |
CORT News
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CORT | 1.87 | +0.11 | +6.25% | 186.65M |
New watchlist
